JULY 19, 2022
Purissima Announces Multi-Year Processing And Distribution Partnership With Open Book Extracts
Purissima is the first biotechnology company to achieve commercial scale production of minor cannabinoids using algae fermentation. In collaboration with Open Book Extracts, the company will officially commercialize before Fall 2022.
JUNE 1, 2022
Leading Biotechnology Company Purissima Showcases First Ever Commercial Scale Production of Cannabinoids Using Algae Fermentation
The company has proven the capacity to produce more than 70 compounds, many of which are hard to replicate minor cannabinoids as well as new plant-powered chemistries with high potential therapeutic value.
APRIL 28, 2022
BioTech Company Purissima Underscores Microalgae’s Capability To Sustainably Produce Pure, Topical Ingredient Alternatives As Global Cannabinoid Demand Is Projected To Reach Over $400B by 2025
Businesses will inevitably rely on innovators like Purissima to offer pure and sustainable ingredients while accounting for scalability, product consistency, and resource traceability.
March 29, 2022
Biotechnology Leader Purissima Receives Three New U.S. Patents
Further validates the platform’s technology advances in the fast-growing bioengineering industry.
November 14, 2019
Innovative Wellness Ingredient Solutions Company, Purissima, Announces Launch
Propietary platform allows for large-scale production of natural, high-demand ingredients for next-generation wellness.